Genetic Technologies has a quick ratio of 0.83. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Genetic Technologies's Quick Ratio or its related term are showing as below:
ASX:GTG's Quick Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.69 * Ranked among companies with meaningful Quick Ratio only.
Genetic Technologies (ASX:GTG) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Genetic Technologies Quick Ratio Related Terms
Genetic Technologies Quick Ratio Historical Data
* Premium members only.
The historical data trend for Genetic Technologies's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:GTG vs LDDD, NOTV, ATLN: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Genetic Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetic Technologies Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Genetic Technologies's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Genetic Technologies's Quick Ratio for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetic Technologies (ASX:GTG) has a Quick Ratio of 0.83 as of Jun. 2024. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genetic Technologies and its competitors.
Is Genetic Technologies' Quick Ratio too high?
Genetic Technologies' current Quick Ratio is 0.83. The Medical Diagnostics & Research industry median Quick Ratio is 1.69. Genetic Technologies' value of 0.83 is 50.9% below this industry median.
How does Genetic Technologies' Quick Ratio compare to LDDD and NOTV?
Genetic Technologies' Quick Ratio of 0.83 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Quick Ratio is 1.69. Genetic Technologies' value of 0.83 is 50.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.69, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genetic Technologies's current Quick Ratio of 0.83 is 50.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genetic Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetic Technologies's current Quick Ratio is 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Technologies stock overvalued right now?
Genetic Technologies (ASX:GTG) has a current Quick Ratio of 0.83. The current Quick Ratio is 0.83 and 50.9% below the Medical Diagnostics & Research industry median of 1.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Genetic Technologies (ASX:GTG), the current Quick Ratio is 0.83 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GTG has been successfully added to your 